Methods and Results: We analyzed a large Japanese family (21 affected and 203 unaffected members) of DCM with AV block. The responsible LMNA mutation of IVS3-10A>G was novel and caused an aberrant splicing. The first clinical manifestation was low-grade AV block or atrial fibrillation (AF), which developed in affected members aged ≥30 years. We observed that the AV block progressed to third-degree within several years. The electrophysiological study of the four affected members revealed an impairment of intra-AV nodal conduction. Because of advanced AV block, pacemakers were implanted in 14 out of 21 affected members at the mean age of 44 years. Three affected members died suddenly and two affected members died of heart failure and/or ventricular tachycardia (VT) even after the pacemaker implantation. Postmortem examination showed conspicuous fibrofatty degeneration of the AV node. Endomyocardial biopsies showed remarkably deformed nuclei and substantial glycogen deposits in the subsarcolemma.
Introduction
Two polypeptides, lamin A and lamin C, are encoded by the lamin A/C gene (LMNA). These arise through alternative splicing of the same primary transcript.
1,2 Lamin A and lamin C proteins are components of the nuclear envelope, forming the inner and the outer nuclear membranes, the nuclear pore complex, and the nuclear lamina. 3 It has been reported that mutations in the LMNA cause various genetic diseases referred to as "laminopathy." 4 To date, seven different types of laminopathies have been established: autosomal dominant 5 /recessive 6 Emery-Dreifuss muscular dys- trophy, limb-girdle muscular dystrophy 1B, 7 familial partial lipodystrophy, 8 sensory and motor axonal neuropathy Charcot-Marie-Tooth disorder type 2, 9 mandibuloacral dysplasia, 10 Hutchinson-Gilford progeria syndrome, 11 and autosomal dominant dilated cardiomyopathy (DCM) with conduction defect. 12 The laminopathies have two major cardiac phenotypes, progressive atrioventricular (AV) block, and myocardial damage. The AV block in the laminopathies is mostly accompanied by cardiomyopathy, but isolated AV block was reported in limb girdle muscular dystrophy 1B 7, 13 and autosomal dominant DCM with conduction defect. 14 We found a large family with DCM with progressive AV block caused by a novel mutation of LMNA and provide the clinical, genetic, electrophysiological, and histopathological findings concerning this particular familial DCM.
Methods

Participation of the Family
This familial DCM was first identified by the high incidence of pacemaker implantation (PMI). We started the investigation of the family because the preliminary study revealed a high incidence of not only PMI but also DCM (Fig. 1A) . Written informed consent was obtained from all participants under approval of the local ethics committee. The family members showing DCM on echocardiogram were designated as affected irrespective of the presence of the conduction defect. The members who died suddenly or died of heart failure without otherwise known causes were also regarded as affected. We collected clinical data of the affected members from the medical records, which included 12-lead electrocardiogram (ECG), transthoratic echocardiogram, and serum creatine kinase. The data of cardiac catheterization and postmortem examination were also evaluated when available. Neurological assessment was performed for clinically affected members by review of medical records, blood examination of serum creatine kinase, and clinical neuromuscular examination evaluated by neurological experts. The family members (≥30 years of age) showing no cardiac phenotypes were designated as unaffected. We examined ECG, echocardiogram, and serum creatine kinase in some unaffected members.
Mutational Analysis of LMNA
We obtained 5-10 mL blood samples from each family member. Genomic DNA was extracted from the whole blood in 25 family members or heart tissue obtained at autopsy. Because the LMNA-mutated DCM with conduction defect was known, we first screened for mutations of LMNA. 12 Twelve coding exons of LMNA were amplified by polymerase chain reaction (PCR) in the proband (IV-70 in Fig. 1A ) as described. 12 Direct sequencing analysis was performed with an automated fluorescence sequencer (ABI PRISM 310, PEBiosystems, Foster City, CA) by the dye-primer cycle sequencing method as described. 15 The PCR-based restriction fragment length polymorphism (PCR-RFLP) analysis was performed in family members and in 100 chromosomes from 50 normal volunteers (randomly selected from our control genomic store, ≥30 years of age) to test whether the mutation was a polymorphism by using a modified forward primer, 5 -CCAGCACTCAGCTCCCAGGT-3 and a reverse primer, 3 -TGGTCTCACGCAGCTCCTGGAAGCG-5 . The underlined nucleotide represents an introduced mismatch, which generated a recognition site for HhaI in DNA fragments amplified from the mutant allele. The thermoprofile consisted of initial denaturing of 95
• C for 3 min, 35 cycles of 98 • C or 10 seconds, 55
• C for 30 seconds, and 72
• C for 30 seconds, followed by 72
• C for 7 min. A total of 10 µL of`PCR products were digested with 10 units of HhaI at 37
• C overnight followed by 4% agarose gel electrophoresis. The DNA flagments were stained with ethidium bromide and visualized on a UV transilluminator.
Analysis of LMNA mRNA of a Lymphoblast Cell Line Established from a Patient
A lymphoblast cell line was established from a blood sample of the proband by Epstein-Barr virus infection. Total RNA was purified from the lymphoblasts with RNeasy Mini kit (Qiagen, Germany) and subjected to reverse transcription as described. 15 A cDNA fragment containing the exon 3/exon 4 junction was amplified by PCR with a forward primer, 5 -GAGAACAGGCTGCAGACCAT-3 , and a reverse primer, 3 -TTGTCAATCTCCACCAGTC G-5 . The RT-PCR products were size-separated by 5% NuSieve GTG agarose (FMC BioProducts, Rockland) gel electrophoresis, and cDNA fragments of 149 bp and 158 bp in size were excised for direct sequencing analysis as described above.
Electrophysiological and Histological Examination
Conventional electrophysiological (EP) study was performed in four affected members because of AV block. Three standard electrode catheters were positioned in the high right atrium, His bundle region, and RV. A quadripolar-catheter or octapolar-catheter was inserted into the coronary sinus and positioned to record the coronary sinus electrogram using each pair of electrodes. The EP study included standard diagnostic protocols for sinus nodal function, AV nodal function, 42 y performed catheter ablation for VT, CK 49 (mU/mL) (< 195 mU/mL) * Clinically affected member whose DNA was not available for the study. AF = atrial fibrillation; AVB = atrioventricular block; CHF = congestive heart failure; CK = creatine kinase; DCM = dilated cardiomyopathy; F = female; LAD = left atrial diameter; LBBB = left bundle branch block; LVEDD/ESD = left ventricular end-diastolic/end-systolic diameter; LVEF = left ventricular ejection fraction; M = male; MD = skeletal muscle disorder; ND = not detectable; y = year; NM = no manifestation; PMI = permanent pacemaker implantation; PVC = premature ventricular contraction; RBBB = right bundle branch block; SD = sudden death; VT = ventricular tachycardia. and ventricular tachycardia (VT) induction. 16 Briefly, in the induction of VT, up to three extrastimuli were induced (coupling intervals ≥ 180 ms) from the apex and the outflow tract of the RV after conditioning pacing (basic cycle length = 600 or 400 ms). If negative, we repeated the protocol above under intravenous administration of isoproterenol (started at 0.5 µg/min, a target heart rate was 20% increase from the control). 17 Histopathological examination was performed in two postmortem heart samples obtained from affected members (IV-72, V-65) and in four biopsied samples of endomyocardial tissues taken from the septum and apex of the RV. Light and electron microscopical analysis was performed.
Results
Clinical Characteristics of Affected Family Members
The clinical characteristics of 21 affected members are summarized in Table 1 . Information concerning the first manifestation was available in six affected members: first-or second-degree AV block and/or atrial fibrillation (AF) initially developed in five of the six affected members, IV-70, V-12, V-65, V-67, and V-69, while affected member IV-72 presented congestive heart failure with AF and third-degree AV block at the onset of the disease (Fig. 2) . The age of onset ranged from 30 to 47 years with a mean age of 40 years. At the first manifestations, all affected members had normal width of QRS complex, and intraventricular conduction delay was not found. Because of the progression to advanced AV block, 14 of the 21 the affected members received pacemakers, and six affected members died before pacemakers were clinically available. One affected member, V-12, was 42 years old and had only first-degree AV block. The mean age of PMI was 44 years with a range of 37-50 years. The PMI was needed within 7 years from the first manifestations such as first-or second-degree AV block and/or AF (Fig. 2) . The width of QRS complex remained normal at the PMI. Fourteen of the 21 affected members have died, and the affected members with pacemakers died at a mean age of 57 (48-71) years, while the affected members without pacemakers died at a mean age of 53 (45-59) years. Sudden death was observed in five of these 14 affected members and six affected members died of congestive heart failure or fatal VT. The affected members, IV-70, V-12, V-65, V-67, and V-69, showed no clinical symptoms of congestive heart failure at the first manifestation. In affected members, IV-70 and V-12, echocardiography revealed normal LV dimensions and cardiac function. After the first manifestation, affected member IV-70 showed the progression of LV dilatation within 3 years. Echocardiogarphical LV dysfunction (LV diameter ≥ 60 mm, or LV ejection fraction ≤40%) was found 6 years after the first manifestation in affected member V-65, 6 years later in affected member V-67, and 9 years later in affected member V-69. The affected member, IV-72, first visited a hospital for clinical heart failure with third-degree AV block. No documentation was available concerning whether heart failure was followed by AV block (Fig. 2) . In the general neurological assessment, no skeletal muscle abnormalities were found by neurological experts or in the review of medical records of clinically affected members in the family. Four genetically affected members (IV-70, IV-72, V-65, and V-69) were extensively evaluated by neurological experts and no manifestation such as Emery-Dreifuss muscular dystropy, limb-girdle muscular dystrophy, or Charcot-Marie-Tooth disorder was found.
Serum creatine kinase was within the normal range in some affected members (IV-70, IV-72, V-65, and V-69).
Identification of LMNA Mutation
All coding regions of LMNA were screened for mutations in a DNA sample of the proband (IV-70). Direct sequencing analysis did not reveal any base change in each exon, but a heterozygous base substitution from adenine to guanine was detected 10-base upstream of the intron 3/exon 4 junction (IVS3-10A>G) (Fig. 1B) . We screened for the IVS3-10A>G by direct sequencing and PCR-RFLP analysis in 19 members (≥30 years of age), which included seven affected (IV-9, IV-70, IV-72, V-12, V-65, V-67, V-69) and 12 unaffected members (III-12, IV-13, IV-14, IV-16, IV-19, IV-28, IV-58, V-3, V-15, V-16, V-17, V-28), and in seven members (<30 years of age) showing no cardiac phenotype (VI-29, VI-30, VI-31, VI-32, VI-33, VI-34, VI-35) whose fathers are affected members. The IVS3-10A>G mutation was detected in all the seven members, but not in all the 12 unaffected members. Furthermore, the mutation was detected in six of the seven members (<30 years of age) showing no cardiac phenotype. Results of the PCR-RFLP analysis are shown in Figure 1A . On the other hand, the mutation was not detected in 100 control alleles (data not shown). These results suggested that the mutation was tightly associated with the disease and that there were mutant carriers (<30 years of age) before the onset of the disease.
The RT-PCR study revealed two cDNA fragments of 149 and 158 bp in size in the proband (data was not shown), while only the 149-bp fragment was observed in the control (data was not shown). Direct sequencing analysis showed that a nine-base fragment, 5 -CCCTTCCAG-3 , was inserted in the junction between exon 3 and exon 4 in the 158-bp fragments (Fig. 1C) . These results suggested that the IVS3-10A > G altered a splicing site to the 10th nucleotide (a/g heterozyzous) upstream from the 3 end of the intron 3 from the junction between the intron 3 and exon 4 (Fig. 1B) . (RBBB+inferior axis type) * During sinus rhythm before EPS, administration of 1.0 mg of atropine sulphate improved Wenckebach-type AV block to one to one AV conduction. AF = atrial fibrillation; EPS = electrophysiological study; LBBB = left bundle branch block; M = male; NI = not induced; NP = not performed; RBBB = right bundle branch block; VT = ventricular tachyardia.
Electrophysiological and Histopathological Characteristics
EP study was performed in four affected members, IV-70, V-65, V-67, and V-69, because of bradycardia and/or spontaneous VT ( Table 2 ). The EP study indicated that affected members, IV-70 and V-65, had AV nodal dysfunction with marked prolongation of the AH interval. In contrast, the HV interval and QRS duration were normal in all four affected members, indicating that the conduction systems of the infra- His bundle to Purkinje fiber and intraventricles might not be impaired. Although affected member, V-65, had AF (Fig.  3A) , the AV conductivity was evaluated after DC defibrillation. He demonstrated Wenckebach-type second-degree AV block ( Fig. 3B ) with prolonged AH interval (Fig. 3C) . Furthermore, VT could be reproducibly induced by programmed stimulation to the outflow tract of the RV (Fig. 3D) .
Heart specimens were obtained at autopsy from affected members, IV-65 and V-72. Microscopical examination disclosed marked fibrofatty degeneration in the AV junction and advanced atrophy of the AV node (Fig. 4A) , and fibrosclerosic degeneration in the AV node associated with decreased numbers of pacemaker cells (Fig. 4B) . Endocardial biopsy of the RV was performed in affected members, IV-46, V-65, V-67, and V-69, and light microscopical examination revealed interstitial fibrosis and contraction band without the disarray arrangement (data are not shown). Electron microscopy demonstrated a large number of deformed nuclei with increased lipofuscin (Fig. 4C) and a prominent accumulation of glycogen deposits beneath the subsarcolemma and around the mitochondria (Fig. 4D) . The nuclear membrane integrity was preserved in all of the examined specimens.
. Light and electron microgram. Light microscopic examination of the AV junction in affected member V-65 by Elastica-Masson staining revealed atrophy of the AV node with fibrofatty degeneration (Panel A). The boxed area in (Panel A) is shown with a higher magnification in (Panel B). The number of pacemaker cells appears to be decreased in the AV node in (Panel B). Electron microscopic analyses of myocardium samples obtained from affected member V-65 by biopsy showed deformed nuclei with increased lipofuscin (Panel C, arrows) and accumulated glycogen granules around the mitochondria and beneath the subsarcolemma (D, arrow heads). Scale bars in (Panel
Discussion
We examined familial DCM with progressive AV block in a large Japanese family and identified a novel LMNA mutation of IVS3-10A>G. Affected members initially showed problems in ECG such as first-or second-degree AV block and/or AF at 30-40 years of age without detectable LV dysfunction. Progression to third-degree AV block was observed in 14 affected members, and they received pacemakers within several years of the first ECG finding. Unfortunately, seven affected members died suddenly or unexpectedly even after the pacemakers were implanted. Some affected members with PMI died from congestive heart failure. The EP study disclosed that the conduction defect occurred predominantly in the AV nodal area as compared with the ventricular area, which was supported by the histological findings that the fibrofatty degeneration was more striking in the AV node than in the atrial or ventricular wall.
The LMNA Mutation in Familial DCM with Conduction Defect
Since introns are noncoding sequences, a mutation in an intron does not usually cause an mRNA abnormality.
However, the present mutation of the intron (IVS3-10A>G) created an aberrant splicing site between intron 3 and exon 4. The missplicing arose at the 10th nucleotide (a/g) upstream of the 5 end from the 3 end of intron 3 (Fig. 1B) , and consequently inserted nine bases to the 5 end of exon 4. The genetic approach strongly indicated that this mutation has a close relation to the clinical phenotype. In fact, the mutation was never found in unaffected family members and 50 volunteers. Although we showed the insertion of the nine bases in the cDNA assay with RT PCR, we did not show the insertion at the protein level. Protein analysis would be important, especially for confirming the present interpretation and for future functional analyses of the protein.
Although the relationship between the mutation site of LMNA and the clinical phenotypes of the laminopathies remains unclear, this mutation was novel and first described in the present study. It also remains unknown why laminopathies due to the LMNA mutations have various clinical phenotypes. Further studies are necessary to elucidate the relationship between the phenotype and the prognosis of laminopathies and the LMNA mutations. [18] [19] [20] The incidence of the LMNA-mutated DCM with AV conduction defect remains controversial. Fatkin 12 studied 11 families with autosomal dominant DCM with conduction defect and identified five LMNA-mutated DCM families (45%). Similarly, LMNA-mutated DCM was found in four of 49 families (8%) by Taylor, 20 two of 16 families (12.5%) by Jakobs, 21 and five of seven (71%) families by Arbustini. 22 Thus, the LMNA mutation may account for 19% of autosomal dominant DCM with conduction defect. Therefore, mutational analysis in LMNA should be first performed for the diagnosis of familial DCM associated with conduction defect.
Electrophysiological Characteristics
The first manifestation in the affected members was firstor second-degree AV block and/or AF, which developed at the mean age of 40 years (range 30-47 years). The EP study revealed AH block, that is, conduction defects in the AV node without those in the infra-Hisian conduction system. The PA interval, which may reflect the intraatrium conductivity, was within the normal range in affected members, IV-70 and V-65, but was prolonged in affected member V-69 whose diseased period had a long history (≥12 years).
Progressive AV block prior to LV dysfunction was unique in affected members with LMNA-mutated DCM. Some in- vestigators have reported a similar time-course of LMNAmutated DCM, that is, the conduction defect, including AV block and AF, developed prior to LV dysfunction, 12,14,20−23 despite different sites of the mutation (Fig. 5) . The present study indicated that the progressive AV block in LMNAmutated DCM was caused by AV nodal impairment without infra-Hisian conduction defect.
AF frequently occurred in LMNA-mutated DCM. 24 However, AF may not be a particular phenotype of LMNA mutations, because LV dysfunction frequently causes AF. It remains unclear how LMNA and its locus, chromosome 1p1-q21, is related to familial AF. [25] [26] [27] [28] [29] Sudden death accounted for 36% (5/14) of all causes of mortality in the LMNA-mutated DCM. Sudden death could not be prevented by PMI, and fatal VT appeared to cause sudden death. In fact, VT could be repeatedly induced by electrical stimulations of the RV in two affected members (V-65 and V-69). Affected member V-69 had spontaneous VT, and affected member V-65 developed spontaneous VT after the EP study. However, the incidence of sudden death is nearly identical to that of patients with DCM (approximately 40%). 30 Therefore, the susceptibility to VT and/or sudden deaths might not be specific to LMNA-mutated DCM; rather, it might be a common clinical feature of chronic heart failure with LV dysfunction.
31,32
Histopathological Characteristics
The microscopical study revealed that fibrosclerotic degeneration occurred predominantly in the AV node. Less severe lesions were also observed in the sinoatrial node, atrium, and ventricular walls. These supported the findings of the clinical examination and EP study that the AV block preceded the other myocardial involvements. The electron microscopical study revealed the accumulation of glycogen deposits beneath the subsarcolemma in the working myocardium in all biopsy samples.
Arbustini 22 reported the fibrosclerotic and fibrofatty degeneration of the AV junction in LMNA-mutated DCM with conduction defect, and described the nuclear membrane damage showed by electron microscopical analysis. 22 Lamin A and lamin C null mice also showed obvious discontinuities in the nuclear envelopes of embryonic fibroblasts and hepatocytes, while those of wild-type and heterozygous mice were intact. 33 However, electron microscopical study in the present report revealed that the nuclear membrane remained intact. This may be related to the sampling site, that is, our biopsy samples were taken from the right ventricle.
Recently, it was reported that mutations in the gene coding the γ 2 regulatory subunit of AMP-activated protein kinase (PRKAG2), an enzyme that modulates glucose uptake and glycolysis, cause glycogen storage disease associated with cardiac hypertrophy and conduction defect including AV block. 34 ,35 Therefore, we may be able to propose the hypothesis that the LMNA mutation causes cellular damage by the intracellular accumulation of glycogen. However, it remains unknown whether a dysfunction of lamin A and lamin C proteins impairs glycogen metabolism. Some types of familial diseases preferentially develop cardiac conduction defects even with a heterogenous genetic background. 27, 36, 37 Understanding the actual molecular mechanism involved in the pathophysiology of familial diseases might enable us to understand the mechanisms of "common" cardiac conduction defects clinically recognized as "sporadic."
Conclusion
This is the first report of the electrophysiological profile of the progressive intra-AV nodal conduction impairment and its histopathological findings in LMNA-mutated DCM. The clinical phenotype of LMNA-mutated DCM in this study was characterized by (1) the first manifestation of the prolonged PQ interval or AF in adolescence, (2) progressive intra AV nodal block to the third degree in several years, and (3) progressive heart failure after PMI. Histological study revealed the preferential degeneration at the AV node area and novel cellular damages in the working myocardium.
